Skip to main content

Table 2 Distribution of laboratory parameter among study participants

From: Clinical profile and outcome of multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19 infection: a single-center observational study from South India

Investigations

Parameters (n)

Mean (SD)

Median

25% quartiles

75% quartiles

COVID 19

Antibodies titer (71)

63.9(49.8)

51.1

32.5

81.6

Hematology

Total leucocytes count/mm3 (71)

12,057.75 (8304.7)

10,600

6200

16,100

Neutrophils (40)

69.1 (11.9)

71

64.25

78

Lymphocytes (40)

25.4 (11.6)

22.5

15.5

29

NL_Ratio (40)

3.5353 (2.1)

3.16

2.21

4.9275

Platelet count (71)

198,450.7 (148,766.5)

160,000

114,000

230,000

Inflammatory indicators

CRP mg/L (71)

110.28 (96.5)

83

42

165

ESR mm 1st hour (51)

62.76 (34.9)

60

35

88

Ferritin ng/ml (39)

1550.23 (5861.9)

401

164

995

LDH IU/L (12)

842.58 (1094.7)

369.5

301.5

859.25

Coagulation profile

D-Dimer micg/ml(35)

2.5 (2.2)

2.1

0.5

3.4

PT (38)

16.3 (3.4)

15.4

14.175

17.175

INR (38)

1.2 (0.3)

1.1

1

1.2

APTT (38)

38.8 (9.8)

37.8

31.75

44

Liver enzymes

SGPT (61)

113.4 (429.9)

35

23

52.5

SGOT (61)

185.3 (710.7)

52

34

69.5

Kidney Function Test

Urea (69)

33.2 (23.3)

26

18

43.45

Creatinine (69)

0.7 (0.6)

0.5

0.3

0.7

  1. NL ratio Neutrophil–lymphocyte ratio, CRP C-reactive protein, ESR Erythrocyte sedimentation, LDH Lactate dehydrogenase, PT Prothrombin time, INR International normalized ratio, APTT Activated partial thromboplastin time, SGPT Serum glutamic pyruvic transaminas, SGOT Serum glutamic oxaloacetic transaminase